Preventing heavy bleeding after C-section
Part of Women’s health & pregnancy clinical trials.
This study compares two ways to prevent heavy bleeding after a C-section. One uses a combination of three medicines, and the other uses a single medicine. The goal is to find which is safer and more effective at reducing blood loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a C-section to deliver your baby.
- You are between 18 and 45 years old.
- You are pregnant with one baby only.
- Your pregnancy is at least 36 weeks along.
- You have no bleeding disorders or blood clotting problems.
- You are not allergic to any of the study medicines.
- You have no major health issues like high blood pressure or heart disease.
- You do not have placenta previa or placenta accreta.
- You have not had blood clots before.
- You do not have preeclampsia or eclampsia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.
This trial tests whether giving a drug called tranexamic acid before a planned C-section can reduce the risk of severe bleeding after birth. It is for women who are otherwise healthy and expecting a single baby.
This trial tests a new under-the-tongue tablet (sublingual oxytocin) to prevent heavy bleeding after childbirth. It aims to see if it works safely in healthy women having a vaginal delivery at full term.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
Hear when a new Post Partum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.